Why the study?
Is non-alcoholic fatty liver disease associated with increased aortic stiffness?
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
NAFLD may prompt vascular risk vigilance; leaves open causal mechanisms and need for prospective trials.
Non-alcoholic fatty liver disease (NAFLD) has become the leading cause of chronic liver diseases worldwide. Liver inflammation and fibrosis related to NAFLD contribute to disease progression and increasing liver-related mortality and morbidity. Increasing data suggest that NAFLD may be linked to atherosclerotic vascular disease independent of other established cardiovascular risk factors. Central arterial stiffness has been recognized as a measure of cumulative cardiovascular risk marker load, and the measure of carotid-femoral pulse wave velocity (cf-PWV) is regarded as the gold standard assessment of aortic stiffness. It has been shown that increased aortic stiffness predicts cardiovascular morbidity and mortality in several clinical settings, including type 2 diabetes mellitus, a well-known condition associated with advanced stages of NAFLD. Furthermore, recently-published studies reported a strong association between NAFLD and increased arterial stiffness, suggesting a possible link in the pathogenesis of atherosclerosis and NAFLD. We sought to review the published data on the associations between NAFLD and aortic stiffness, in order to better understand the interplay between these two conditions and identify possible common physiopathological mechanisms.
No takes yet. Share an insight, caveat, or question.
Villela‐Nogueira et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: